Cargando…

TREM2 as an evolving therapeutic target in Alzheimer’s disease

Detalles Bibliográficos
Autor principal:	George, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358665/ https://www.ncbi.nlm.nih.gov/pubmed/37449620 http://dx.doi.org/10.4103/1673-5374.371360

Ejemplares similares

Trimming Trem2 and possible impacts on the metabolic syndrome
por: Shapiro, Hagit, et al.
Publicado: (2022)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
por: Zhong, Li, et al.
Publicado: (2019)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Does Soluble TREM2 Protect Against Alzheimer's Disease?
por: Brown, Guy C., et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

TREM2 regulates innate immunity in Alzheimer’s disease
por: Li, Jiang-Tao, et al.
Publicado: (2018)

TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
por: Zhou, Yingyue, et al.
Publicado: (2018)

New insights into the role of TREM2 in Alzheimer’s disease
por: Gratuze, Maud, et al.
Publicado: (2018)

Plasmonic Interferometers as TREM2 Sensors for Alzheimer’s Disease
por: Li, Dingdong, et al.
Publicado: (2021)

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023)

TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
por: Huang, Wendi, et al.
Publicado: (2023)

The Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders
por: Yaghmoor, Faris, et al.
Publicado: (2014)

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
por: Henjum, Kristi, et al.
Publicado: (2016)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
por: Zheng, Honghua, et al.
Publicado: (2018)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
por: Yang, Jiaolong, et al.
Publicado: (2020)

Reduced TREM2 activation in microglia of patients with Alzheimer's disease
por: Okuzono, Yuumi, et al.
Publicado: (2021)

TREM2 dependent and independent functions of microglia in Alzheimer’s disease
por: Hou, Jinchao, et al.
Publicado: (2022)

Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2013)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

The therapeutic potential of TREM2 in cancer
por: Wolf, Elysa M., et al.
Publicado: (2022)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

TREM-1 as a Potential Therapeutic Target in Psoriasis
por: Hyder, Luke A., et al.
Publicado: (2013)

Metastasis, an Example of Evolvability
por: Laruelle, Annick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ac4jkcp986d87ca39g7d44tb7h